Drug Evaluation Committee Results of Questionnaire on the Status of Introduction of DCT and DCT Methods
Data Science Subcommittee
October 2024
The Data Science Subcommittee released "Data Flow in DCT and Ensuring Reliability" in August 2022 regarding "Decentralized Clinical Trial (DCT)," which is a clinical trial method that does not depend on visits to medical institutions, and in the report, the status of introduction of DCT conducted in FY2021 is shown. The Data Science Subcommittee also summarized the results of a questionnaire survey conducted in FY2021 on the status of introduction of DCT and issues related to each method.
In Task Force 1-2 of the Data Science Subcommittee FY2023, a similar questionnaire survey was conducted again with the aim of confirming changes in the status of DCT implementation since FY2021. This deliverable includes the changes since FY2021, new issues that have emerged as implementation has progressed for some methods, and recommendations and points to keep in mind regarding ensuring reliability. We hope that this report will not only disseminate information on the use of DCTs, but also help to further introduce and promote DCTs.
Japan Pharmaceutical Manufacturers Association, Committee on Drug Evaluation
Data Science Subcommittee Task Force 1-2 for FY2023
Deliverables of the Drug Evaluation Committee Return to list of all deliverables